|
|||||
|
|
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway. |
|
| Authors: | H Yasui T Hideshima H Ikeda E M Ocio T Kiziltepe S Vallet Y Okawa P Neri K Sukhdeo K Podar D Chauhan P G Richardson N Raje D R Carrasco K C Anderson |
| Institution: | Jerome Lipper Multiple-Myeloma Center, Department of Medical-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. |
| Abstract: | |
| Keywords: | |